Courtney Oakes
Family · Moultrie, GANPI 1033830609
Payments from drug & device makers
Across 313 payments — averaging $17.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$860
- Pfizer$631
- AstraZeneca$445
- Amgen$348
- Otsuka America Pharmaceutical, Inc.$344
- Bayer$334
- plus $2K from 30 others
What the payments were for
- Food & beverage$5,457100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 44 | $860 |
| Pfizer | 44 | $631 |
| AstraZeneca | 22 | $445 |
| Amgen | 22 | $348 |
| Otsuka America Pharmaceutical, Inc. | 17 | $344 |
| Bayer | 20 | $334 |
| Lilly USA, LLC | 22 | $333 |
| Novo Nordisk | 9 | $253 |
| Boehringer Ingelheim | 12 | $218 |
| Shield Therapeutics Inc | 16 | $175 |
| Lundbeck LLC | 8 | $170 |
| GSK | 10 | $166 |
| Corcept Therapeutics | 10 | $164 |
| Astellas Pharma US Inc | 2 | $133 |
| Merck | 7 | $109 |
| Corium, LLC | 6 | $103 |
| Axsome Therapeutics, Inc. | 4 | $79 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 5 | $77 |
| Sumitomo Pharma America, Inc. | 4 | $71 |
| Novartis | 4 | $62 |
| Exact Sciences | 4 | $61 |
| Ironwood Pharmaceuticals, Inc | 3 | $45 |
| Ardelyx, Inc. | 2 | $38 |
| Teva Pharmaceuticals USA, Inc. | 2 | $33 |
| Ultragenyx Pharmaceutical Inc. | 1 | $22 |
| Ironshore Pharmaceuticals Inc. | 1 | $21 |
| Vertex | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
| Kowa Pharmaceuticals America, Inc. | 1 | $17 |
| Phathom Pharmaceuticals, Inc. | 3 | $15 |
| Halozyme Inc | 1 | $15 |
| Antares Pharma, Inc. | 1 | $15 |
| Scpharmaceuticals Inc. | 1 | $15 |
| Sanofi Pasteur Inc. | 1 | $15 |
| Aimmune Therapeutics, Inc. | 1 | $14 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,457 in reported general payments places this provider in the 90th percentile of 6,258 family providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 16 | $16,530 |
| OzempicSemaglutide | 15 | $16,195 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 16 | $10,045 |
| LinzessLinaclotide | 11 | $8,558 |
| Duloxetine Hcl | 17 | $1,222 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 43 | $1,014 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 54 | $646 |
| Gabapentin | 53 | $542 |
| Ventolin HfaAlbuterol Sulfate | 11 | $505 |
| Pantoprazole Sodium | 51 | $481 |
| Fluticasone Propionate | 29 | $449 |
| Cefdinir | 32 | $441 |
| Atorvastatin Calcium | 44 | $411 |
| Omeprazole | 15 | $406 |
| Doxycycline Hyclate | 37 | $367 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro | $333 | $16,53016 claims |
| Novo NordiskOzempic | $253 | $16,19515 claims |
| GSKTrelegy Ellipta | $166 | $10,04516 claims |
| AbbVieLinzess | $860 | $8,55811 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 6,258 family providers in Georgia.
Other family in Moultrie
- Allie McAllisterMarietta$299K
- Tonita WashingtonLawrenceville$153K
- Erin HenryLawrenceville$135K
- Trisha RomanPeachtree City$134K
- Lori ReedMarietta$106K
- Julia BranchCumming$102K
- Hannah BanachWaycross$85K
- Morgan GroothandEvans$81K
- Anna Carolina WrightLilburn$69K
- Jessica FeehanCanton$51K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.